INSM Q4 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+5.7% YoY

Gross Profit

$46M78.0% margin

Operating Income

-$151M-255.4% margin

Net Income

-$160M-270.0% margin

EPS (Diluted)

$-1.21

QoQ Revenue Growth

-12.4%

Cash Flow

Operating Cash Flow

-$103M

Free Cash Flow

-$108M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.6B

Stockholders' Equity

$88M

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$56M	+5.7%
Gross Profit	$46M	$43M	+7.9%
Operating Income	-$151M	-$99M	-52.9%
Net Income	-$160M	-$113M	-41.7%

Geographic Segments

UNITED STATES

$48M76%

JAPAN

$15M24%